BIOPROJET PHARMA has a total of 13 patent applications. It increased the IP activity by 900.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PROXIMAGEN LLC, KRONOS BIO INC and ACHE LAB FARMACEUTICOS SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Lecomte Jeanne-Marie | 9 |
#2 | Schwartz Jean-Charles | 9 |
#3 | Capet Marc | 8 |
#4 | Labeeuw Olivier | 5 |
#5 | Marc Capet | 2 |
#6 | Labeeuw Oliver | 2 |
#7 | Jeanne-Marie Lecomte | 2 |
#8 | Olivier Labeeuw | 2 |
#9 | Jean-Charles Schwartz | 2 |
#10 | Schwartz Jean Charles | 1 |
Publication | Filing date | Title |
---|---|---|
EP3378477A1 | New therapeutical use of h3-ligands |